Literature DB >> 9600825

Malignant melanoma metastatic to the ovary: presentation and radiological characteristics.

M Moselhi1, J Spencer, G Lane.   

Abstract

Cutaneous melanomas rarely metastasize to the ovary; however, we have recently encountered three cases which have proved a diagnostic dilemma. All presented with a pelvic mass and a past history of cutaneous melanoma but both ultrasound examination and CT scanning proved inconclusive and neither was able to accurately characterize the lesions. Magnetic resonance imaging (MRI) was able to demonstrate the presence of melanin in one of the ovarian lesions as peripheral high signal change on T1-weighted images. The two lesions without melanin failed to show this feature. MRI may therefore be useful in the diagnosis of ovarian melanoma but only if melanin is present. Copyright 1998 Academic Press.

Entities:  

Mesh:

Year:  1998        PMID: 9600825     DOI: 10.1006/gyno.1998.4992

Source DB:  PubMed          Journal:  Gynecol Oncol        ISSN: 0090-8258            Impact factor:   5.482


  4 in total

1.  Metastatic ovarian malignant melanoma with no obvious primary.

Authors:  Ateş Karateke; Niyazi Tuğ; Davut Sahin
Journal:  J Turk Ger Gynecol Assoc       Date:  2011-09-01

2.  A case of metastatic malignant melanoma of the ovary with a multilocular cystic appearance on MR imaging.

Authors:  Yoko Abe; Mayumi Takeuchi; Kenji Matsuzaki; Hisanori Uehara; Hiroyuki Furumoto; Hiromu Nishitani
Journal:  Jpn J Radiol       Date:  2009-12-25       Impact factor: 2.374

3.  Diagnostic challenge for ovarian malignant melanoma in premenopausal women: primary or metastatic?

Authors:  Yassir Sbitti; Zouhour Fadoukhair; Habiba Kadiri; Mohamed Oukabli; Ismail Essaidi; Saoussan Kharmoum; Hind M'rabti; Abderrahmane Albouzidi; Mohammed Ichou; Hassan Errihani
Journal:  World J Surg Oncol       Date:  2011-06-17       Impact factor: 2.754

4.  Delayed malignant melanoma recurrence simulating primary ovarian cancer: case report.

Authors:  Anastasios Boutis; Rosalia Valeri; Ippokratis Korantzis; Dimitrios Valoukas; Ioannis Andronikidis; Charalambos Andreadis
Journal:  World J Surg Oncol       Date:  2008-11-20       Impact factor: 2.754

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.